Pay in 4 interest-free payments of $6.84 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Join Hundreds of Patients Seeing Real Results with Dr
Sources Lilly investor news Eli Lilly FDA drug approval process FDA.gov Related reading Retatrutide Phase 3 Results 2026: TRIUMPH Trial Tracker Living tracker of every retatrutide trial TRIUMPH-1/2/3/4/5, TRIUMPH-Outcomes, TRANSCEND-T2D-1/2, and SYNERGY-OUTCOMES Phase 3 readouts
Local injection site reactions were uncommon in the Phase 2 trial, occurring at a lower frequency than systemic gastrointestinal events
$169 every 3 weeks From: $169 every 3 weeks From: $169 every 3 weeks The Platform gives you full access to the frontcare partner ecosystem:
For patients with existing cardiovascular risk factors, this safety profile matters significantly
US$ 23.60
US$ 22.89
US$ 22.70
US$ 25.67
US$ 28.03
US$ 24.79
US$ 28.39
US$ 24.74
US$ 20.82
